{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:7385"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:7385","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"The molecular epidemiology and characteristics of methicillin resistant Staphylococcus aureus sequence type 22 in a local, national and international context.","abstract":"The globally distributed, ciprofloxacin resistant hospital associated methicillin resistant Staphylococcus aureus (MRSA) lineage epidemic (E)MRSA-15 (sequence type 22) continues to expand into new healthcare systems around the world. To further understand the evolution of EMRSA-15, which has been proposed to have emerged in the West Midlands, a large collection of contemporaneous and historical Birmingham isolates were studied alongside a collection of International genomes. Through generation of phylogentic trees this study has been able to determine that EMRSA-15 emerged in c1984 and that during this time a highly related healthcare associated ciprofloxacin sensitive ST22 population was present in Birmingham. A dominant, geographically restricted EMRSA-15 clone was also identified in Birmingham (designated the BHM clone). Analysis of the impact of fluoroquinolone use on the Birmingham EMRSA-15 phylogeny showed increasing use of fluoroquinolones (the introduction of ofloxacin) coincided with the emergence of the BHM clone. Further evidence of geographically restricted EMRSA-15 clones were found in Guernsey and Hong Kong; demonstrating localized evolution giving rise to distinct island populations. Comparison of the desiccation tolerance of geographically restricted and non-restricted EMRSA-15 clones indicated enhanced environmental survival as a possible reason for the spread and dominance of the restricted lineages.","abstract_html":"The globally distributed, ciprofloxacin resistant hospital associated methicillin resistant Staphylococcus aureus (MRSA) lineage epidemic (E)MRSA-15 (sequence type 22) continues to expand into new healthcare systems around the world. To further understand the evolution of EMRSA-15, which has been proposed to have emerged in the West Midlands, a large collection of contemporaneous and historical Birmingham isolates were studied alongside a collection of International genomes. Through generation of phylogentic trees this study has been able to determine that EMRSA-15 emerged in c1984 and that during this time a highly related healthcare associated ciprofloxacin sensitive ST22 population was present in Birmingham. A dominant, geographically restricted EMRSA-15 clone was also identified in Birmingham (designated the BHM clone). Analysis of the impact of fluoroquinolone use on the Birmingham EMRSA-15 phylogeny showed increasing use of fluoroquinolones (the introduction of ofloxacin) coincided with the emergence of the BHM clone. Further evidence of geographically restricted EMRSA-15 clones were found in Guernsey and Hong Kong; demonstrating localized evolution giving rise to distinct island populations. Comparison of the desiccation tolerance of geographically restricted and non-restricted EMRSA-15 clones indicated enhanced environmental survival as a possible reason for the spread and dominance of the restricted lineages.","abstract_has_math":false,"creators":["Thomson, Calum Bryson"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2017,"date_issued":"2017-07","date_published":"2017-07","updated_at":"2026-11-19T09:29:25Z","subjects":["QR Microbiology","RA0421 Public health. Hygiene. Preventive Medicine"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/7385/1/Thomson17PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A7385","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["nihr"]},{"key":"dc:creator","label":"Author","values":["Thomson, Calum Bryson"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2017-07"]},{"key":"dc:date.issued","label":"Date","values":["2017-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Microbiology and Infection"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/7385/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QR Microbiology","RA0421 Public health. Hygiene. Preventive Medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/7385/1/Thomson17PhD.pdf","http://etheses.bham.ac.uk//id/eprint/7385/8/Decl_IS_Thomson17PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The globally distributed, ciprofloxacin resistant hospital associated methicillin resistant Staphylococcus aureus (MRSA) lineage epidemic (E)MRSA-15 (sequence type 22) continues to expand into new healthcare systems around the world. To further understand the evolution of EMRSA-15, which has been proposed to have emerged in the West Midlands, a large collection of contemporaneous and historical Birmingham isolates were studied alongside a collection of International genomes. Through generation of phylogentic trees this study has been able to determine that EMRSA-15 emerged in c1984 and that during this time a highly related healthcare associated ciprofloxacin sensitive ST22 population was present in Birmingham. A dominant, geographically restricted EMRSA-15 clone was also identified in Birmingham (designated the BHM clone). Analysis of the impact of fluoroquinolone use on the Birmingham EMRSA-15 phylogeny showed increasing use of fluoroquinolones (the introduction of ofloxacin) coincided with the emergence of the BHM clone. Further evidence of geographically restricted EMRSA-15 clones were found in Guernsey and Hong Kong; demonstrating localized evolution giving rise to distinct island populations. Comparison of the desiccation tolerance of geographically restricted and non-restricted EMRSA-15 clones indicated enhanced environmental survival as a possible reason for the spread and dominance of the restricted lineages."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public","staffonly"]},{"key":"dc:title","label":"Title","values":["The molecular epidemiology and characteristics of methicillin resistant Staphylococcus aureus sequence type 22 in a local, national and international context."]}]}],"canonical_facts":{"dc:contributor.sponsor":["nihr"],"dc:creator":["Thomson, Calum Bryson"],"dc:date":["2017-07"],"dc:date.issued":["2017-07"],"dc:description.abstract":["The globally distributed, ciprofloxacin resistant hospital associated methicillin resistant Staphylococcus aureus (MRSA) lineage epidemic (E)MRSA-15 (sequence type 22) continues to expand into new healthcare systems around the world. To further understand the evolution of EMRSA-15, which has been proposed to have emerged in the West Midlands, a large collection of contemporaneous and historical Birmingham isolates were studied alongside a collection of International genomes. Through generation of phylogentic trees this study has been able to determine that EMRSA-15 emerged in c1984 and that during this time a highly related healthcare associated ciprofloxacin sensitive ST22 population was present in Birmingham. A dominant, geographically restricted EMRSA-15 clone was also identified in Birmingham (designated the BHM clone). Analysis of the impact of fluoroquinolone use on the Birmingham EMRSA-15 phylogeny showed increasing use of fluoroquinolones (the introduction of ofloxacin) coincided with the emergence of the BHM clone. Further evidence of geographically restricted EMRSA-15 clones were found in Guernsey and Hong Kong; demonstrating localized evolution giving rise to distinct island populations. Comparison of the desiccation tolerance of geographically restricted and non-restricted EMRSA-15 clones indicated enhanced environmental survival as a possible reason for the spread and dominance of the restricted lineages."],"dc:format":["application/pdf"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/7385/1/Thomson17PhD.pdf","http://etheses.bham.ac.uk//id/eprint/7385/8/Decl_IS_Thomson17PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Microbiology and Infection"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/7385/"],"dc:subject":["QR Microbiology","RA0421 Public health. Hygiene. Preventive Medicine"],"dcterms:accessrights":["public","staffonly"],"dc:title":["The molecular epidemiology and characteristics of methicillin resistant Staphylococcus aureus sequence type 22 in a local, national and international context."],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:29:25Z"}